114 related articles for article (PubMed ID: 29858176)
1. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.
Kiltz U; van der Heijde D; Boonen A; Akkoc N; Bautista-Molano W; Burgos-Vargas R; Wei JC; Chiowchanwisawakit P; Dougados M; Duruoz MT; Elzorkany BK; Gaydukova I; Gensler LS; Gilio M; Grazio S; Gu J; Inman RD; Kim TJ; Navarro-Compan V; Marzo-Ortega H; Ozgocmen S; Pimentel Dos Santos F; Schirmer M; Stebbings S; Van den Bosch FE; van Tubergen A; Braun J
Ann Rheum Dis; 2018 Sep; 77(9):1311-1317. PubMed ID: 29858176
[TBL] [Abstract][Full Text] [Related]
2. The ASAS Health Index and Environmental Factors Item Set: validity and reliability of the Swedish translations in Swedish patients with ankylosing spondylitis.
Feldthusen C; Hallström M; d'Elia A; Deminger A; Kiltz U; Forsblad-d'Elia H
Scand J Rheumatol; 2024 Mar; 53(2):104-111. PubMed ID: 37905707
[TBL] [Abstract][Full Text] [Related]
3. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
Di Carlo M; Lato V; Carotti M; Salaffi F
Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study.
Couderc M; Pereira B; Molto A; Tiple A; Soubrier M; Dougados M
J Rheumatol; 2018 Jun; 45(6):795-801. PubMed ID: 29657148
[TBL] [Abstract][Full Text] [Related]
5. Altered sleep in axial spondyloarthritis and psoriatic arthritis: Post hoc comparative study based on a sleep-specific question from the ASAS health index.
Alonso S; Morante I; Braña I; Queiro R
Reumatol Clin (Engl Ed); 2023 Oct; 19(8):430-435. PubMed ID: 37805256
[TBL] [Abstract][Full Text] [Related]
6. Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort.
Redeker I; Landewé R; van der Heijde D; Ramiro S; Boonen A; Dougados M; Braun J; Kiltz U
RMD Open; 2023 Dec; 9(4):. PubMed ID: 38123481
[TBL] [Abstract][Full Text] [Related]
7. The assessment of Spondyloarthritis International Society Health Index (ASAS HI) in patients with spondyloarthritis - a single centre experience.
Skokić M; Ćosićkić A; Alić A
Med Glas (Zenica); 2024 Feb; 21(1):118-125. PubMed ID: 38341638
[TBL] [Abstract][Full Text] [Related]
8. Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.
Lekpa FK; Poulain C; Wendling D; Soubrier M; De Bandt M; Berthelot JM; Gaudin P; Toussirot E; Goupille P; Pham T; Sellam J; Bruckert R; Paul M; Farrenq V; Claudepierre P;
Arthritis Res Ther; 2012 Mar; 14(2):R53. PubMed ID: 22404969
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial.
Molto A; López-Medina C; Van den Bosch FE; Boonen A; Webers C; Dernis E; van Gaalen FA; Soubrier M; Claudepierre P; Baillet A; Starmans-Kool M; Spoorenberg A; Jacques P; Carron P; Joos R; Lenaerts J; Gossec L; Pouplin S; Ruyssen-Witrand A; Sparsa L; van Tubergen A; van der Heijde D; Dougados M
Ann Rheum Dis; 2021 Nov; 80(11):1436-1444. PubMed ID: 33958325
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis.
Bello N; Etcheto A; Béal C; Dougados M; Moltó A
Arthritis Res Ther; 2016 Feb; 18():42. PubMed ID: 26860612
[TBL] [Abstract][Full Text] [Related]
11. Human Leukocyte Antigen B*27-Negative Spondyloarthritis: Clinical, Serological, and Radiological Features of a Single-Center Cohort.
Mariani FM; Alunno A; Di Ruscio E; Altieri P; Ferri C; Carubbi F
Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066792
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drug use is determined by disease activity in axSpA and decreased by biologicals: a longitudinal analysis.
Durak Ediboğlu E; Solmaz D; Kabadayı G; Gücenmez S; Cinakli H; Otman Akat E; Özmen M; Akar S
ARP Rheumatol; 2023; 2(4):322-329. PubMed ID: 38174752
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Juvenile Spondyloarthritis Disease Flare Measure: Ascertaining Flare in Patients With Inactive Disease.
Weiss PF; Brandon TG; Ryan ME; Treemarcki EB; Armendariz S; Wright TB; Godiwala C; Stoll ML; Xiao R; Lovell D
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):373-380. PubMed ID: 34363343
[TBL] [Abstract][Full Text] [Related]
14. Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
Zhou J; Huang W; Zhang Z; Luo L; Ren F; Huang D; Tang L
Clin Rheumatol; 2023 Dec; 42(12):3251-3255. PubMed ID: 37740841
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice.
Webers C; El-Din RN; Beckers E; Been M; Vonkeman HE; van Tubergen A
Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38048595
[TBL] [Abstract][Full Text] [Related]
16. Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar.
Al Emadi S; Hadwan NN; Saleh R; Satti E; Singh R
Open Access Rheumatol; 2024; 16():21-29. PubMed ID: 38283655
[TBL] [Abstract][Full Text] [Related]
17. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.
Garrett S; Jenkinson T; Kennedy LG; Whitelock H; Gaisford P; Calin A
J Rheumatol; 1994 Dec; 21(12):2286-91. PubMed ID: 7699630
[TBL] [Abstract][Full Text] [Related]
18. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D; Cheng-Chung Wei J; Dougados M; Mease P; Deodhar A; Maksymowych WP; Van den Bosch F; Sieper J; Tomita T; Landewé R; Zhao F; Krishnan E; Adams DH; Pangallo B; Carlier H;
Lancet; 2018 Dec; 392(10163):2441-2451. PubMed ID: 30360964
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.
van der Linden S; Valkenburg HA; Cats A
Arthritis Rheum; 1984 Apr; 27(4):361-8. PubMed ID: 6231933
[TBL] [Abstract][Full Text] [Related]
20. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.
Kiltz U; Landewé RBM; van der Heijde D; Rudwaleit M; Weisman MH; Akkoc N; Boonen A; Brandt J; Carron P; Dougados M; Gossec L; Jongkees M; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compán V; Niederman K; Sampaio-Barros PD; Slobodin G; Van den Bosch FE; van Tubergen A; van Weely S; Wiek D; Braun J
Ann Rheum Dis; 2020 Feb; 79(2):193-201. PubMed ID: 31604704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
